Literature DB >> 28063325

A pilot trial of In vivo NRT sampling to increase medication adherence in community corrections smokers.

Karen L Cropsey1, Peter S Hendricks2, Samantha Schiavon3, Aaron Sellers4, Morgan Froelich5, Richard C Shelton6, Matthew J Carpenter7.   

Abstract

BACKGROUND: Individuals in the criminal justice system demonstrate high rates of cigarette use (70-80%) and low adherence to smoking cessation medication. Educational approaches have not been shown to promote adherence or cessation, though medication sampling has boosted both use and cessation. The objective of the present study was to determine whether In vivo nicotine replacement therapy (NRT) sampling approach increases NRT adherence among criminal justice smokers during a subsequent quit attempt.
METHODS: We conducted a pilot study with 43 community corrections smokers randomized to a 4-session (one 30-min session per week) precessation intervention of either In vivo NRT sampling (Session 1: patch; Session 2: gum; Session 3: combination NRT (cNRT); Session 4: review) vs. 4 time-matched sessions of standard smoking cessation with cNRT started after Session 1. Both groups received an additional 8weeks of cNRT following the four intervention sessions.
RESULTS: During the in vivo administration of NRT, total withdrawal and craving severity significantly decreased from pre- to post-session compared to Control participants. In vivo participants evinced greater patch use at Session 4 and greater gum use through Week 8 relative to Controls. DISCUSSION: In vivo NRT sampling may increase NRT adherence relative to standard counseling sessions among criminal justice smokers. A larger trial of this novel intervention appears to be warranted.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Craving; Medication adherence; Nicotine replacement therapy; Withdrawal

Mesh:

Year:  2016        PMID: 28063325     DOI: 10.1016/j.addbeh.2016.12.011

Source DB:  PubMed          Journal:  Addict Behav        ISSN: 0306-4603            Impact factor:   3.913


  6 in total

1.  Interventions to increase adherence to medications for tobacco dependence.

Authors:  Gareth J Hollands; Felix Naughton; Amanda Farley; Nicola Lindson; Paul Aveyard
Journal:  Cochrane Database Syst Rev       Date:  2019-08-16

2.  Can we increase smokers' adherence to nicotine replacement therapy and does this help them quit?

Authors:  Tanya R Schlam; Jessica W Cook; Timothy B Baker; Todd Hayes-Birchler; Daniel M Bolt; Stevens S Smith; Michael C Fiore; Megan E Piper
Journal:  Psychopharmacology (Berl)       Date:  2018-04-25       Impact factor: 4.530

3.  In vivo Experience With NRT to Increase Adherence and Smoking Abstinence Among Individuals in the Criminal Legal System: Study Protocol for a Randomized Clinical Trial.

Authors:  Elizabeth S Hawes; Sofía Mildrum Chana; Alexandra Faust; Julianne C Baker; Peter S Hendricks; Andres Azuero; Adrienne C Lahti; Matthew J Carpenter; Karen L Cropsey
Journal:  Front Psychiatry       Date:  2022-06-21       Impact factor: 5.435

Review 4.  Practice Quit Attempts: Scoping Review of a Novel Intervention Strategy.

Authors:  Chelsea M Cox; Jennifer C Westrick; Danielle E McCarthy; Matthew J Carpenter; Amanda R Mathew
Journal:  J Stud Alcohol Drugs       Date:  2022-01       Impact factor: 2.582

5.  Pragmatic randomised trial of a smartphone app (NRT2Quit) to improve effectiveness of nicotine replacement therapy in a quit attempt by improving medication adherence: results of a prematurely terminated study.

Authors:  Aleksandra Herbec; Jamie Brown; Lion Shahab; Robert West; Tobias Raupach
Journal:  Trials       Date:  2019-09-02       Impact factor: 2.279

6.  A Pilot Randomized Clinical Trial of Remote Varenicline Sampling to Promote Treatment Engagement and Smoking Cessation.

Authors:  Matthew J Carpenter; Kevin M Gray; Amy E Wahlquist; Karen Cropsey; Michael E Saladin; Brett Froeliger; Tracy T Smith; Benjamin A Toll; Jennifer Dahne
Journal:  Nicotine Tob Res       Date:  2021-05-24       Impact factor: 4.244

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.